BioCatalystWatch
PLRXWorkspace / PLRX / OverviewCompany library
PLIANT THERAPEUTICS, INC. logo

PLIANT THERAPEUTICS, INC.

PLIANT THERAPEUTICS, INC. (PLRX)

Website

Price
Market cap
Next catalystExpected 2027PLN-101095 — FORTIFY; dose escalation and indication expansion with pembrolizumab · Phase 1 dataCompany release ↗
Cash

Chart & Events

Candle interval

Core Clinical

PLN-101095

αvβ8 integrin × αvβ1 integrin

PreINDP1P2P3FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

PLN-101095

αvβ8 integrin × αvβ1 integrin

PreINDP1P2P3FilingApproved
Upcoming / outlook

Other pipelines

PLN-101325

α7β1 integrin

PLN-101325

α7β1 integrin

PreINDP1P2P3FilingApproved

History / paused

αvβ6 integrin × αvβ1 integrin

PreINDP1P2P3FilingApproved

αvβ6 integrin × αvβ1 integrin

PreINDP1P2P3FilingApproved

αvβ6 integrin × αvβ1 integrin

PreINDP1P2P3FilingApproved

αvβ6 integrin × αvβ1 integrin

PreINDP1P2P3FilingApproved

αvβ1 integrin

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

PLRX PR & News

PR & News

PLRX SEC archive